Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.31 +0.11 (+5.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Rocket Pharmaceuticals (RCKT) Total Debt (2014 - 2021)

Updated

Rocket Pharmaceuticals' Total Debt came in at $5.1 million for Q2 2021, up 2.3% from the prior quarter.

Analysis

Rocket Pharmaceuticals (RCKT) Total Debt (2014 - 2021) Analysis & Trends

At the end of FY2020, Rocket Pharmaceuticals' Total Debt was $4.88 million.

  • The Q2 2021 figure represents the highest quarterly Total Debt since Q4 2014.
  • Business Quant data shows RCKT's Total Debt at $4.99 million (Q1 2021), $4.88 million (Q4 2020) and $4.77 million (Q3 2020) in the three quarters before Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 44.65 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 70.82 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 32.35 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 26.25 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 63.19 Bn
10 Rocket Pharmaceuticals 258.98 Mn -24.72 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 5.10 Mn
Mar 31, 2021 4.99 Mn
Dec 31, 2020 4.88 Mn
Sep 30, 2020 4.77 Mn
Dec 31, 2014 5.61 Mn
API Access

Rocket Pharmaceuticals Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=RCKT&period=max&api_key=YOUR_API_KEY